Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Crispr Therapeutics Ag
(NQ:
CRSP
)
53.54
+2.00 (+3.88%)
Streaming Delayed Price
Updated: 1:03 PM EDT, May 17, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
639,999
Open
52.68
Bid (Size)
53.39 (2)
Ask (Size)
53.52 (3)
Prev. Close
51.54
Today's Range
51.69 - 53.92
52wk Range
42.51 - 169.76
Shares Outstanding
77,457,081
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Analyst Ratings for CRISPR Therapeutics
Today 12:03 EDT
Over the past 3 months, 11 analysts have published their opinion on CRISPR Therapeutics (NASDAQ:CRSP) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
How to Buy Stocks in a Recession
May 16, 2022
The same strategies for buying stocks during a bull market don't apply during a recession. Learn what you need to do going forward.
Via
InvestorPlace
Performance
YTD
-34.47%
-34.47%
1 Month
-8.85%
-8.85%
3 Month
-8.65%
-8.65%
6 Month
-37.07%
-37.07%
1 Year
-50.98%
-50.98%
More News
Read More
5 Cathie Wood Stocks to Buy Now
May 16, 2022
Via
InvestorPlace
Crispr Therapeutics Rallies As It Plots Out Its Next Cancer Move Vs. Gilead, Novartis
May 12, 2022
Via
Investor's Business Daily
Why This Analyst Has 'Little Conviction' On CRISPR's Upcoming Trial Data
May 10, 2022
Via
Benzinga
$100 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth This Much
May 02, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022
April 28, 2022
Via
Benzinga
What 4 Analyst Ratings Have To Say About CRISPR Therapeutics
April 28, 2022
Via
Benzinga
3 Cathie Wood Stocks to Count on in Q2
April 26, 2022
Via
InvestorPlace
7 Potential Biotech Stocks Buyout Targets in 2022
April 21, 2022
Via
InvestorPlace
$1000 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth This Much
April 20, 2022
Via
Benzinga
Here's How Much $1000 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today
April 01, 2022
Via
Benzinga
3 Best Stocks to Trade Right Now
March 24, 2022
Via
InvestorPlace
Fed Rate Hike Rallies Stocks
March 17, 2022
Via
Talk Markets
Here's How Much $1000 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today
March 16, 2022
Via
Benzinga
3 Ark Invest Most-Shorted Stocks to Buy
March 11, 2022
Via
InvestorPlace
7 Cathie Wood Stocks That Are Worth Buying in March
March 10, 2022
Via
InvestorPlace
3 Cathie Wood Stocks to Buy
March 09, 2022
Via
InvestorPlace
Tough Slogging Ahead for Investors, Diversification is Important
March 07, 2022
Via
Talk Markets
Intellia Therapeutics Crashes As Patent Decision Clouds CRISPR Gene-Editing Test
February 28, 2022
Via
Investor's Business Daily
Peloton Isn’t the ONLY Takeover Target. What Companies Could Be Bought Out in 2022?
February 23, 2022
Via
InvestorPlace
Why Jim Cramer Believes Sirius XM Is Inexpensive
February 23, 2022
Via
Benzinga
What Are Whales Doing With CRISPR Therapeutics
February 22, 2022
Via
Benzinga
CRISPR Therapeutics's Return On Capital Employed Insights
February 16, 2022
Via
Benzinga
Week In Review: Xbiome Acquires Diabetic Foot Ulcer Therapy In $139 Million Deal
January 29, 2022
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.